Metis Genetics Advisors

 

ALBERTO L. ROSA, MD PhD

Trusted Advisor, Neurogenetics and International Affairs

Alberto is a Medical Geneticists and Molecular biologists with expertise in general Clinical Genetics, Neurogenetics and Molecular Diagnostics. He obtained his academic degrees in both Medicine and Chemistry, completing his two PhD degrees in the respective disciplines (e.g. Clinical Genetics and Molecular Biology). Dr. Rosa developed his clinical and medical research activities in both France and the US, being Associate Professor at Baylor College of Medicine (TX), Research Professor at Washington State University (WA) and Co-Director of the Molecular Diagnostic Laboratory of the Sacred Heart Medical Center (WA).  Dr. Rosa’s corporate experience includes the founding of a successful Molecular Diagnostic Laboratory (GENBIOMOL) and serving as Chief Medical Officer (CMO) and Board Director. He was recognized by the Howard Hughes Medical Institute as an International Researcher (1997-2002) and has received numerous awards both for teaching and for research. Dr. Rosa has published about 50 peer-reviewed articles on topics related to clinical genetics and molecular biology and is currently Chairman of the Department of Clinical Genetics and Director of the Molecular Diagnostics laboratory of Sanatorio Allende (Argentina). He is also an advisor of the Latin America’s Teletons, health care organizations devoted to patients with rare diseases, neuromuscular disorders and inherited diseases. His medical consulting expertise included patients from all around the world, including The US, Europe, Mexico as well as Central and South America.  Dr. Rosa contributes to Metis his international expertise in genetics as well as his knowledge on the richness of the wide cultural identities among Spanish patients.


Stephanie M. Ware, MD PhD

Trusted Advisor, Cardiogenetics

Stephanie Ware.jpg

Stephanie M. Ware, MD, PhD, is a Professor of Pediatrics and Medical and Molecular Genetics, Vice Chair of Clinical Affairs in Medical and Molecular Genetics, and Program Leader in Cardiovascular Genetics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine.  Dr. Ware graduated Summa cum laude with highest honors in Zoology from Butler University. She earned her MD and PhD degrees at the University of Cincinnati College of Medicine where she was elected to Alpha Omega Alpha Honor Society. She completed her pediatric residency and clinical genetics fellowship at Baylor College of Medicine in Houston, Texas.  Dr. Ware’s research interests include the genetic and developmental basis of disorders of cardiac structure and function. Her research laboratory has made significant contributions in the areas of congenital heart defects and cardiomyopathy. Dr. Ware is a member of the American Heart Association, the American Society for Human Genetics, the Society for Pediatric Research, the American Society for Clinical Investigation, and is Faculty of the American College of Medical Genetics and Genomics. She has received a number of scholarly awards for her research. Dr. Ware has a longstanding track record of independent funding from the NIH and multiple foundations for basic and translational research. In addition, she participates in multi-site initiatives including serving as PI of the Genetic Coordinating Center for the NHLBI funded study to identify genotype-phenotype correlations in pediatric cardiomyopathy and serving as PI for the Cytogenomics of Cardiovascular Malformations Consortium. The long term goals of the clinical, translational, and basic research approaches are to identify causes and potential management of disorders of cardiac structure and function.  Clinically, she evaluates and manages patients with genetic disorders and has specific expertise in cardiomyopathy and syndromes with cardiovascular disease. She was recruited to IUSM in March, 2014 to initiate a cardiovascular genetics program that would encompass clinical cardiovascular genetics services and basic and translational cardiovascular genetics research.


L. Thomas Richards, MD

Trusted Advisor, Finance and Corporate Strategy

Richards_250x300.jpg

Dr. Richards has more than 20 years of professional experience in the industries of healthcare and finance. Most recently, he served as the interim CEO of One BioMed, a Singapore-based molecular diagnostics company developing novel, silicon biophotonics technology for clinical infectious disease testing at the point-of-care. He also serves as a Senior Advisor to two US-based companies: (1) Nanomix, an immunology-based point-of-care diagnostics company focused in the areas of sepsis and cardiology for the emergency medicine market, and (2) Metis Genetics, a B-to-B genetic counseling services platform. Prior to that, he led an emerging molecular diagnostics company as the CEO of TessArae, which designed genetic tests for the reproductive health and infectious disease markets.

Dr. Richards became a life sciences executive after practicing as an academic physician on the clinical faculty of Stanford University and UCSF, where he was most recently an Assistant Professor of Emergency Medicine. Before attending medical school, Dr. Richards began his career as an investment banker in the mergers and acquisitions groups of several firms in New York, including Lazard Frères, UBS and SG Cowen. He has broad transactional experience in finance, having executed buy and sell-side M&A assignments, public and private capital raisings and leveraged buyouts.

Dr. Richards also has more than a decade of experience in board leadership. He has served as a Director of both public and private companies, including: Cowen Group (an investment bank/hedge fund); TessArae and One BioMed (life sciences firms); and Witt/Kieffer.

Education
M.D., Harvard Medical School, Boston, MA
M.Phil., English, University of Sydney, Sydney, Australia
B.A., English, Yale University, New Haven, CT